Abstract
This guide outlines the current recommended dosimetry guidelines for the treatment of benign thyroid diseases, such as Graves’ disease and toxic adenoma, using radioactive iodine iodine-131. In this article, patient preparation, measurement setup, uptake probe, measurement methods, calculation techniques, and potential sources of error required for dosimetry are discussed. Additionally, two different patient cases with dosimetry-based treatment dose calculations are presented for routine clinical practice.
Keywords: Treatment of hyperthyroidism, dosimetry, dosimetry of benign thyroid diseases
References
Çelen YZ. Benign tiroid hastalıklarının tedavisinde nükleer tıp uygulamaları. Çelen YZ, editör. Tiroid ve paratiroid bezi hastalıklarının tanı ve tedavisinde nükleer tıp uygulamaları. 1. Baskı. Ankara: Türkiye Klinikleri; 2021. p.11-18.
Kravets I. Hyperthyroidism: diagnosis and treatment. Am Fam Physician. 2016;95:363-370.
Özdoğan Ö, Güzin Töre G, Özkılıç H, Kır M, Yüksel D. TNTD, I-131 ile hipertiroidizm tedavi uygulama kılavuzu 2.0. Nükleer Tıp Seminerleri / Nuclear Medicine Seminars. 2015;1:44-49.
Burch HB, Burman KD, Cooper DS. A 2011 survey of clinical practice patterns in the management of Graves’ disease. J Clin Endocrinol Metab. 2012;97:4549-4558.
Stokkel MPM, Junak DH, Lassmann M, Dietlein M, Luster M. EANM procedure guidelines for therapy of benign thyroid disease. Eur J Nucl Med Mol Imaging. 2010;37:2218-2228.
Bartalena L, Burch HB, Burman KD, Kahaly GJ. A 2013 European survey of clinical practice patterns in the management of Graves’ disease. Clin Endocrinol (Oxf). 2016;84:115-120.
Benua RS, Cicale NR, Sonenberg M, Rawson RW. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer. Am J Roentgenol Radium Ther Nucl Med. 1962;87:171-182.
Maxon HR, Thomas SR, Hertzberg VS, et al. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med. 1983;309:937-941.
Hänscheid H, Canzi C, Eschner W, et al. EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. dosimetry prior to radioiodine therapy of benign thyroid diseases. Eur J Nucl Med Mol Imaging. 2013;40:1126-1134.
Demir M, Yeyin N. Teranostiklerle tedavide dozimetrik yaklaşım: 131 tedavilerinde dozimetri. Özcan Z, editör. Nükleer onkolojide teranostik uygulamalar. 1. Baskı. Ankara: Türkiye Klinikleri; 2018. p.11-15.
Radyonüklit tedavisi gören hastalarin taburcu edilmesine ilişkin kılavuz. Erişim linki:https://webim.ndk.gov.tr/file/a1bf6826-7456-42dd-a839-0e96964c033f
